On December 18, 2025, in Foster City, California, Geron Corporation, a biopharmaceutical company listed on Nasdaq with ticker symbol GERN, announced the granting of stock options to a newly hired employee. The options allow the purchase of 320,000 shares of common stock and were given on December 17, 2025, to incentivize the employee's acceptance of the job offer at Geron.